Business Description
Kingworld Medicines Group Ltd
ISIN : KYG5268M1006
Compare
Compare
Traded in other countries / regions
01110.Hong Kong IPO Date
2000-01-04Description
Kingworld Medicines Group Ltd is engaged in Distribution sales of pharmaceutical and healthcare products such as branded imported pharmaceutical and healthcare products primarily in Hong Kong and the PRC, and Manufacturing and sales of electrotherapeutic and physiotherapeutic devices and general medical examination devices primarily carried out in the PRC. It derives the majority of its revenue from Distribution sales of pharmaceutical and healthcare products segment.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.55 | |||||
| Equity-to-Asset | 0.46 | |||||
| Debt-to-Equity | 0.57 | |||||
| Debt-to-EBITDA | 3.36 | |||||
| Interest Coverage | 5.44 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 1.94 | |||||
| Beneish M-Score | -2.37 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 11.5 | |||||
| 3-Year EBITDA Growth Rate | -0.1 | |||||
| 3-Year EPS without NRI Growth Rate | 23.8 | |||||
| 3-Year Book Growth Rate | -1.2 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 89.13 | |||||
| 9-Day RSI | 70.08 | |||||
| 14-Day RSI | 58.61 | |||||
| 6-1 Month Momentum % | -27.78 | |||||
| 12-1 Month Momentum % | -34.18 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.27 | |||||
| Quick Ratio | 1.02 | |||||
| Cash Ratio | 0.42 | |||||
| Days Inventory | 45.05 | |||||
| Days Sales Outstanding | 35.65 | |||||
| Days Payable | 66.71 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 4.57 | |||||
| Dividend Payout Ratio | 0.45 | |||||
| 3-Year Dividend Growth Rate | -2.6 | |||||
| Forward Dividend Yield % | 6.26 | |||||
| 5-Year Yield-on-Cost % | 3.15 | |||||
| Shareholder Yield % | -10.7 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 26.02 | |||||
| Operating Margin % | 5.81 | |||||
| Net Margin % | 3.53 | |||||
| FCF Margin % | 3.92 | |||||
| ROE % | 5.96 | |||||
| ROA % | 2.86 | |||||
| ROIC % | 3.97 | |||||
| ROC (Joel Greenblatt) % | 30.66 | |||||
| ROCE % | 13.19 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 7.89 | |||||
| PE Ratio without NRI | 10.57 | |||||
| Shiller PE Ratio | 7.9 | |||||
| PEG Ratio | 8.81 | |||||
| PS Ratio | 0.28 | |||||
| PB Ratio | 0.51 | |||||
| Price-to-Tangible-Book | 0.59 | |||||
| Price-to-Free-Cash-Flow | 7.18 | |||||
| Price-to-Operating-Cash-Flow | 7.18 | |||||
| EV-to-EBIT | 4.45 | |||||
| EV-to-EBITDA | 4.44 | |||||
| EV-to-Revenue | 0.43 | |||||
| EV-to-FCF | 11.09 | |||||
| Price-to-Projected-FCF | 0.29 | |||||
| Price-to-Median-PS-Value | 0.51 | |||||
| Price-to-Graham-Number | 0.52 | |||||
| Earnings Yield (Greenblatt) % | 22.47 | |||||
| FCF Yield % | 13.27 | |||||
| Forward Rate of Return (Yacktman) % | 19.4 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kingworld Medicines Group Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 1,179.815 | ||
| EPS (TTM) (HK$) | 0.071 | ||
| Beta | 1.06 | ||
| Volatility % | 48.39 | ||
| 14-Day RSI | 58.61 | ||
| 14-Day ATR (HK$) | 0.022156 | ||
| 20-Day SMA (HK$) | 0.514 | ||
| 12-1 Month Momentum % | -34.18 | ||
| 52-Week Range (HK$) | 0.485 - 0.92 | ||
| Shares Outstanding (Mil) | 622.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kingworld Medicines Group Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kingworld Medicines Group Ltd Stock Events
| Event | Date | Price(HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Kingworld Medicines Group Ltd Frequently Asked Questions
What is Kingworld Medicines Group Ltd(HKSE:01110)'s stock price today?
The current price of HKSE:01110 is HK$0.55. The 52 week high of HKSE:01110 is HK$0.92 and 52 week low is HK$0.49.
When is next earnings date of Kingworld Medicines Group Ltd(HKSE:01110)?
The next earnings date of Kingworld Medicines Group Ltd(HKSE:01110) is .
Does Kingworld Medicines Group Ltd(HKSE:01110) pay dividends? If so, how much?
The Dividend Yield %  of Kingworld Medicines Group Ltd(HKSE:01110) is 4.57% (As of Today), Highest Dividend Payout Ratio of Kingworld Medicines Group Ltd(HKSE:01110) was 0.9. The lowest was 0.12. And the median was 0.42. The  Forward Dividend Yield % of Kingworld Medicines Group Ltd(HKSE:01110) is 6.26%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers